NOT-AI-10-042: Notice of Clarification for AI-10-009 Martin Delaney Collaboratory: Towards an HIV-1 Cure (U19)

Notice of Clarification for AI-10-009 Martin Delaney Collaboratory: Towards an HIV-1 Cure (U19)

Notice Number: NOT-AI-10-042

Key Dates

Release Date: September 16, 2010

Issued by

National Institute of Allergy and Infectious Diseases (NIAID)

Purpose

The purpose of this Notice is to change a section of the National Institute of Allergy and Infectious Diseases (NIAID) FOA, RFA-AI-10-009 http://grants1.nih.gov/grants/guide/rfa-files/RFA-AI-10-009.html, to provide clarification of the intent of the FOA.

Under Section III Eligibility Information, 1.B., Eligible Individuals in the 5th paragraph currently states:

A PD/PI, or PD/PI on a multi-PI application, or U19 PL may serve as a collaborator for another application provided there is no scientific overlap with the application submitted by the PD/PI, multi-PD/PI, or U19 PL. However, an investigator may only be a PD/PI, multi-PD/PI, or U19 PL on one application.

It should be replaced with the following languag:

In the 6th (next) paragraph, the following has sentence has been modified to read as follows: (the correction is identified in bold italics)

The PD/PI (or in the case of a multi-PI application, the contact PD/PI) must devote at least 2.4 person months effort to the project (this includes a minimum 0.6 person months effort to the management and operations activities).

All other aspects of this FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Sandra Bridges, Ph.D.
Division of AIDS
National Institutes of Allergy and Infectious Diseases
Room 4154, MSC-7626
6700B Rockledge Drive
Bethesda, MD 20892-7626
Telephone: (301) 496-8198
Fax: (301) 402-3211
Email: [email protected]

Jeymohan Joseph, Ph.D.
Division of AIDS Research
National Institute of Mental Health
Room 6219, MSC-9619
6001 Executive Boulevard
Bethesda, MD 20892-9619
Telephone: (301) 443-3012
Fax: (301) 443-9719
Email: [email protected]